Blue Jet Healthcare’s Board of Directors has approved the unaudited standalone financial results for the quarter and half-year ended September 30, 2025. The company reported a profit of ₹521.36 million for the quarter and ₹1,433.07 million for the half-year. Earnings per share (EPS) stood at ₹3.01 for the quarter and ₹8.26 for the half-year.
Financial Performance
Blue Jet Healthcare announced its unaudited standalone financial results for the quarter ended September 30, 2025 (Q2 2026). Key highlights from the financial results are as follows:
Key Financial Highlights
- Revenue from Operations: ₹1,654.81 million for the quarter and ₹5,202.39 million for the six months ended September 30, 2025.
- Other Income: ₹242.71 million for the quarter and ₹325.25 million for the six months ended September 30, 2025.
- Profit Before Tax: ₹687.27 million for the quarter and ₹1,915.87 million for the six months ended September 30, 2025.
- Total Tax Expense: ₹165.91 million for the quarter and ₹482.80 million for the six months ended September 30, 2025.
- Profit for the period: ₹521.36 million for the quarter and ₹1,433.07 million for the six months ended September 30, 2025.
- Earnings per share (EPS): ₹3.01 (Basic and Diluted) for the quarter and ₹8.26 (Basic and Diluted) for the six months ended September 30, 2025.
Balance Sheet Summary
Key figures from the company’s balance sheet as of September 30, 2025:
- Total Assets: ₹15,274.60 million.
- Equity Share Capital: ₹346.93 million.
Cash Flow Statement Summary
The cash and cash equivalents at the end of the period stood at ₹669.98 million.
Source: BSE
